MicroPort sells its first Toumai endoscopic surgery robot abroad in quest to go global

MicroPort claims that it stands out for real-time 3D vision, precise control of the surgical arms, dexterous manipulation within a narrow space, among other benefits.

MicroPort (微创医疗, HK:00853), a leading surgical robot developer in China, announced yesterday that its iconic endoscopic Toumai™ robot had received its first order overseas, marking a crucial step for the firm toward globalizing its operation.

According to an official WeChat post, the company said it sold the first Toumai™ surgery robot to an unnamed overseas client thanks to its “overseas sales channels, cutting-edge innovations, stable product performance and sound training service system.”

The sale was hailed as a “brand new breakthrough” for a domestically built laparoscopic surgical robot, a piece of high-end medical equipment, to make its foray into the global market, the post said.

The Toumai™ model is a four-armed surgical robot tailored to laparoscopic surgeries. MicroPort claims that it stands out for real-time 3D vision, precise control of the surgical arms, dexterous manipulation within a narrow space, among other benefits.

The product completed its first successful surgery for robot assisted laparoscopic radical prostatectomy (RALRP) at Dongfang Hospital in Shanghai on November 1, 2019.

RALRP was provided to a patient, who was admitted to the hospital for early prostate cancer, says an online product brochure.

MicroPort stated on December 8 this year that as of early November 2023, the Toumai™ surgery robot had assisted in 1,500 operations conducted by urological, general surgery, thoracic, and gynecological departments at close to 60 hospitals in 21 provinces, municipalities and ethnic autonomous regions across the country.

Among them, the robot took part in over 80 5G-powered telesurgeries, MicroPort claimed.

Toumai™ and other surgery devices from the company, including Honghu, or Skywalker, are seen as China’s answers to Intuitive Surgical’s world-famous Da Vinci Xi robotic surgical platform.

Avatar photo
Ni Tao

Ni Tao is the founder and editor-in-chief of cnrobopedia. Prior to cnrobopedia, he had a full decade of experience with a major state-run English-language newspaper as a tech reporter and opinion writer. He is also a communications specialist, having provided consultancy services to established firms like Siemens, Philips, ABinBev, Diageo, Trip.com Group (Nasdaq: TCOM, HK: 9961), Jianpu Technology (NYSE: JT) and a handful of domestic startups. A graduate of Fudan University, he writes widely about China's business and tech scenes and other topics for global publications including South China Morning Post, SupChina, The Diplomat, CGTN, Banking Technology, among others, and tries to impart his experience to students at Fudan University Journalism School, where he is a part-time lecturer. When he's not writing about robotics, you can expect him to be on his beloved Yanagisawa saxophones, trying to play some jazz riffs, often in vain and occasionally against the protests of an angry neighbor. Get in touch with him by dropping a line at nitao0927@gmail.com.

Articles: 785